Toronto Dominion Bank’s Ultragenyx Pharmaceutical RARE Stock Holding History

Toronto Dominion Bank’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.39K	Sell	162 -31,538	-99%	-$710K	﹤0.01%	1986
2025 Q4	$729K	Buy	+31,700	New	+$1.04M	﹤0.01%	1315
2022 Q4	–	Sell	-19,700	Closed	-$816K	–	1575
2022 Q3	$816K	Buy	+19,700	New	+$1.01M	﹤0.01%	1128
2020 Q2	–	Sell	-30	Closed	-$1K	–	1351
2020 Q1	$1K	Hold	30	–	–	﹤0.01%	1208
2019 Q4	$1K	Buy	+30	New	+$1.24K	﹤0.01%	1315

Other funds holding RARE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Toronto Dominion Bank's RARE Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Ultragenyx Pharmaceutical (RARE) stake by 99% in Q1 2026, selling an estimated $710K and leaving 162 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #1986.

Toronto Dominion Bank first reported a position in RARE in Q4 2019 and has held it in 5 quarters since. The position peaked at $816K in Q3 2022. 295 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

Toronto Dominion Bank held 162 shares of Ultragenyx Pharmaceutical worth $3.39K as of Q1 2026.
Toronto Dominion Bank sold 31,538 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $710K.
Ultragenyx Pharmaceutical made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q1 2026, its #1986 holding.
Toronto Dominion Bank first reported a position in Ultragenyx Pharmaceutical in Q4 2019 and has held it in 5 quarters since.
Toronto Dominion Bank's Ultragenyx Pharmaceutical position peaked at $816K in Q3 2022.
295 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.